Protein-Based Nonvolatile Memory via Amino Acid Chelation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional silicon-based resistive switching devices have low biocompatibility, making them unsuitable for wearable information processing devices and biomedical applications, and existing protein-based devices face limitations in immunogenicity and control over conductive filament formation.

Innovation Solution

A protein-based nonvolatile memory device using a protein switching layer with amino acids and active electrode materials like copper, silver, and zinc, where the formation of conductive filaments is controlled by voltage and pH to vary resistance states, and a method for fabricating this device involving thermal denaturation and precise control of protein solutions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If silicon-based materials are used in resistive switching devices, then device performance and reliability are improved, but biocompatibility deteriorates

Engineering Contradiction:
Improvedevice reliabilityVSAvoidbiocompatibility
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the material parameter from silicon-based inorganic materials to protein-based organic materials, fundamentally altering the chemical composition to achieve biocompatibility while maintaining resistive switching functionality through amino acid chelation mechanisms

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite structure combining protein switching layers with metal electrodes (Cu, Ag, Al, Ni, Fe, Co, Zn), where the protein layer provides biocompatibility and the metal electrodes provide electrical conductivity and active material for chelation-based conductive filament formation

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If natural proteins are used as insulating layers in RS devices, then biocompatibility is improved, but control over conductive filament formation deteriorates

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidconductive filament formation control
Core Design Contradiction:
Object-affected harmful factorsVSManufacturing precision

Solution Approach 1:

The patent changes the pH parameter of the protein solution to control the protonation state of amino acids, which directly affects chelation strength and conductive filament formation. By adjusting pH, the patent achieves precise control over filament formation while maintaining protein-based biocompatibility

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent establishes a feedback mechanism where pH control of the protein solution regulates amino acid chelation behavior, which in turn controls conductive filament formation and resistance state transitions, enabling reversible and controllable switching operation

Inventive Principle:
Principle #23Feedback

3Object-affected harmful factors

If amino acid chelation is used to form conductive filaments, then biocompatibility is improved, but manufacturing complexity increases

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidmanufacturing process complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent uses pH adjustment as a simple parameter change to control amino acid chelation, avoiding complex manufacturing processes. By changing only the pH of the protein solution, the patent controls filament formation without requiring additional processing steps or complex equipment

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device alleviates immunogenicity issues and improves the characteristics of nonvolatile memory devices by precisely controlling conductive filament formation, enabling their use in bioimplants and offering low-power, high-reliability performance suitable for biomedical and wearable applications.

Implementation Method 1

the amino acid chelates with an active electrode material to form a conductive filament

Methodology Applied
Scientific EffectChelation:

Implementation Method 2

a method for fabricating the protein-based nonvolatile memory device that improves the characteristics of the RS device by precisely controlling the formation of conductive filaments

Methodology Applied
Scientific EffectThermal denaturation:

Data Source

PatentUS10700273B2Protein-based nonvolatile memory device and method for manufacturing the same
Publication Date: 2020.06.30 RES & BUSINESS FOUND SUNGKYUNKWAN UNIV
  • US10700273B2 patent drawing
  • US10700273B2 patent drawing
  • US10700273B2 patent drawing

AI summary

In a first aspect of the present disclosure, there is provided a nonvolatile memory device comprising: two electrodes; and a protein switching layer interposed between the two electrodes and including an amino acid, wherein then a voltage is applied to one of the electrodes, the amino acid chelates with an active electrode material to form a conductive filament, wherein the formation of the conductive filament allows a resistance state of the device to vary.